We are live on ! Find out more
HURA

TuHURA Biosciences
HURA

21 hedge funds and large institutions have $3.95M invested in TuHURA Biosciences in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

486% more capital invested

Capital invested by funds: $674K → $3.95M (+$3.28M)

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

40% more funds holding

Funds holding: 15 → 21 (+6)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
21
Holders Change
+6
Holders Change %
+40%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$1.22M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.05M
3
S
swisspartners
Liechtenstein
+$533K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$295K
5
Citadel Advisors
Citadel Advisors
Florida
+$149K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$22K
2
Squarepoint
Squarepoint
New York
-$15K
3
GSEP
Golden State Equity Partners
California
-$14K
4
TRCT
Tower Research Capital (TRC)
New York
-$10K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
– -$10K -5 Closed
1
2

HURA Hedge Fund Activity: Q1 2021 in Review

21 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q1 2021, worth a combined $3.95M — up 486% from $674K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new HURA positions and 4 closed out — a net gain of 6 holders — while 6 added to existing stakes and 0 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $1.22M. The largest seller was Two Sigma Investments, exiting entirely with an estimated $22K sold.

  • 21 institutional investors held TuHURA Biosciences (HURA) as of Q1 2021, up from 15 in Q4 2020.
  • Funds reported $3.95M of TuHURA Biosciences stock for Q1 2021, up 486% quarter-over-quarter.
  • 10 funds opened new TuHURA Biosciences positions in Q1 2021 and 4 closed out, a net change of +6 holders.
  • The largest TuHURA Biosciences buyer in Q1 2021 was Nantahala Capital Management, an estimated $1.22M added.
  • The largest TuHURA Biosciences seller in Q1 2021 was Two Sigma Investments, an estimated $22K sold.

Based on aggregated 13F filings for Q1 2021.